Becton, Dickinson and Co. vs Johnson & Johnson
BDX vs JNJ — side-by-side comparison from reported financials. BDX leads 3, JNJ leads 8 of 11 comparable metrics.
Becton, Dickinson and Co.
BDX · Healthcare
$183.75+0.55%Strained
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | BDX | JNJ |
|---|---|---|
| Price | $183.75 | $261.79 |
| Market cap | $50.0B | $631B |
| Revenue (TTM) | $20.1B | $97.9B |
| Revenue growth | +5.0% | +5.6% |
| Net margin | 4.7% | 21.5% |
| Free cash flow | $2.73B | $22.2B |
| Net cash (debt) | ($18.5B) | ($27.8B) |
| 1-year price return | -2.8% | +37.0% |
| P/E | 53.1 | 29.9 |
| P/E vs own history (cheap-side %) | 31% | 16% |
| Dividend yield | 2.34% | 2.00% |
| Return on equity | 4% | 26% |
| Altman Z-score | 1.95 | — |
| CV checks passed | 7 of 11 | 10 of 11 |
| Employees | 72,000 | 140,800 |
Full résumé-style profiles: BDX CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.